000			02182nam a22003615i 4500
999			_c80382 _d80382
001			80382
003			ES-MaUEC
005			20230208150055.0
007			cr nn 008mamaa
008			140925s2014 gw | s |||| 0|eng d
020			_a9783319030593
024	7		_a10.1007/978-3-319-03059-3 _2doi
040			_aES-MaUEC _bspa
050		4	_aRC280.L8 _bC377 2014
100	1		_aCappuzzo, Federico. _946097
245	1	0	_aGuide to Targeted Therapies : _bEGFR mutations in NSCLC _cby Federico Cappuzzo
260			_aCham _bSpringer International Publishing _bImprint: Adis _c2014.
300			_a1 recurso en línea (XI, 67 páginas) _b16 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aIntroduction -- The Human Epidermal growth factor Receptor (HER)â€f̄amily:â€s̄tructure and function -- Methods for EGFR mutation testing -- Predictive and prognostic implications of EGFR mutations -- EGFR-targeted therapies in nonâ€{u3B61}ll cell lung cancer -- Conclusions.
520	3		_aGuide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide.
650	2	7	_aFarmacoterapia _2embne _9671142
650	2	7	_aAparato respiratorio _xEnfermedades _2embne _9405936
710	2		_aSpringerLink (Online service) _0Local _9106996
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-03059-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12881351 _b10-10-17 _c11-11-15
942			_2lcc _cLE
945			_aRC280.L8 C377 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11561178 _z06-04-17
988			_aEBOOK, asignarmaterias, EBSPRINGER,
998			_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _ggw _h0